evelopment of cDC1s has become a topic of interest because of the critical role this lineage plays in antitumor immunity and checkpoint blockade therapy . Dendritic cells (DCs) are an immune lineage encompassing classical DCs (cDCs) and plasmacytoid DCs (pDCs) 2, 3 . The cDCs comprise two branches, cDC1 and cDC2, which exert distinct functions in vivo and rely on different transcriptional programs 4 . pDCs and cDCs can both arise from the CDP [5] [6] [7] . cDC progenitors (pre-cDCs) include clonogenic populations separately committed to cDC1 or cDC2 lineages 8, 9 . Similar progenitors have been confirmed in human DC development [10] [11] [12] .
D
evelopment of cDC1s has become a topic of interest because of the critical role this lineage plays in antitumor immunity and checkpoint blockade therapy 1 . Dendritic cells (DCs) are an immune lineage encompassing classical DCs (cDCs) and plasmacytoid DCs (pDCs) 2, 3 . The cDCs comprise two branches, cDC1 and cDC2, which exert distinct functions in vivo and rely on different transcriptional programs 4 . pDCs and cDCs can both arise from the CDP [5] [6] [7] . cDC progenitors (pre-cDCs) include clonogenic populations separately committed to cDC1 or cDC2 lineages 8, 9 . Similar progenitors have been confirmed in human DC development [10] [11] [12] .
However, the precise transcriptional programs underlying DC specification and commitment remain unclear.
The transcription factors interferon regulatory factor 8 (Irf8) and basic leucine zipper transcription factor, ATF-like 3 (Batf3) are required for cDC1 development 9, 13, 14 , but cDC1s develop from CDPs that express Irf8 independently of Batf3, yet later become dependent on Batf3 to maintain Irf8 expression. The basis for this switch from Batf3-independent to Batf3-dependent Irf8 expression is unclear. A clonogenic cDC1 progenitor, the pre-cDC1, develops normally in Batf3 −/− bone marrow (BM) but fails to maintain Irf8 expression 9 , causing it to divert into cells that are transcriptionally similar to cDC2 15 . An enhancer located at +32 kilobases (kb) of the Irf8 transcriptional start site contained several AP1-IRF composite elements that bind IRF8 and BATF3 in cDC1s in vivo 9 . CRISPRmediated deletion of the +32-kb Irf8 enhancer in mice (Irf8 +32 −/− ) suggests that Batf3 supports Irf8 autoactivation using this enhancer.
Similar to Batf3
−/− mice, Irf8 +32 −/− mice lack mature cDC1s but maintain pre-cDC1 development in vivo. Instead, the development of this progenitor depends on a +41-kb Irf8 enhancer, which binds E-proteins and is active in mature pDCs and cDC1 progenitors, but not mature cDC1s. In vivo deletion of this enhancer eliminated Irf8 expression in pDCs and also completely eliminated development of the specified pre-cDC1. This enhancer activity requires E-proteins to induce sufficient levels of IRF8 during specification of the precDC1, but it is still unclear why mature cDC1s require BATF3 and the +32-kb Irf8 enhancer to maintain Irf8 expression.
Other transcription factors are known to influence cDC1 development, such as nuclear factor, interleukin 3, regulated (Nfil3), inhibitor of DNA binding 2 (Id2) and zinc finger E-box binding homeobox 2 (Zeb2) (refs. [16] [17] [18] [19] [20] ). NFIL3, a basic leucine zipper transcriptional repressor 21 , is expressed in cDC1s and is required for cDC1 development 16, 22 , but how it functions is unknown 4, 16 . ID2 is a known inhibitor of E-proteins, is expressed in both cDC1 and cDC2, but is required only for cDC1 development 17, 18 . ID2 may exclude pDC fate by blocking the activity of E-proteins, particularly E2-2 (Tcf4), required for pDCs [23] [24] [25] . However, this model predicts that Id2 −/− mice should lack both cDC1 and cDC2 lineages, because both lineages must exclude pDC fate. Finally, the transcriptional repressor ZEB2 is required for pDC development and suppresses cDC1 development, perhaps through inhibition of Id2 transcription 19, 20 . How these factors precisely interact and at what stage they influence cDC1 specification is unknown.
In the present study, single-cell RNA-sequencing (scRNA-seq) and genetic epistasis were used to determine the functional hierarchy of transcription factors involved in cDC1 specification. A transcriptional circuit was organized to explain the switch in Irf8 expression from being Batf3 independent to being Batf3 dependent. The CDP originates in a Zeb2 hi and Id2 lo state in which Irf8 expression is maintained by the +41-kb Irf8 enhancer. The scRNA-seq identified a fraction of the CDP that exclusively possesses cDC1 fate potential. This fraction's development arises when Nfil3 induces a transition into a Zeb2 lo and Id2 hi state. A circuit of mutual Zeb2-Id2 repression serves to stabilize states before and after this transition. Id2 expression in the specified pre-cDC1 inhibits E-proteins, blocking activity of the +41-kb Irf8 enhancer, thereby imposing a new requirement for Batf3 to maintain Irf8 expression via the +32-kb Irf8 enhancer.
Results
The earliest committed cDC1 progenitor arises within the CDP. The CDP was originally defined as a Lin -CD117 int CD135 + CD115 + BM population and was observed to be, although not defined as, largely negative for major histocompatibility complex II (MHC-II) and CD11c expression 6 . Subsequently, pre-cDC1 and pre-cDC2 progenitors were identified as arising from the CDP but were not contained within the CDP 8, 9 . Pre-cDC1s were defined as Lin -CD117 int CD135 +
CD11c
+ MHC-II lo-int cells and were largely CD115 -. They can be defined using two methods, relying either on Zbtb46-GFP expression in Zbtb46 gfp/+ reporter mice, or on conventional surface markers (Fig. 1a ) 9, 26 . In each case, it was noticed that approximately 10% of pre-cDC1s expressed CD115. The expression of CD115 in the pre-cDC1 suggested that cDC1 specification could occur at an earlier developmental stage in the CDP. In agreement, 5-10% of CDPs, defined on the strict exclusion of CD11c-and MHC-II-expressing cells, are Zbtb46-GFP pos (Fig. 1b) . These Zbtb46-GFP pos CDPs had almost exclusive cDC1 potential in an in vitro Fms-related tyrosine kinase 3 ligand (Flt3L) culture, comparable to pre-cDC1s, and completely lacked pDC and cDC2 potential. This was in contrast to the Zbtb46-GFP neg CDPs, which produced cells from all three DC lineages ( Fig. 1c and see Supplementary Fig. 1a) .
The transcriptional profile of these Zbtb46-GFP pos CDPs suggests that they represent an intermediate population between a non-specified CDP, the Zbtb46-GFP neg CDP and the pre-cDC1 (Fig. 1d,e CDPs was reduced by 9-fold in pre-cDC1s, but only by 3.6-fold in Zbtb46-GFP pos CDPs. As expected, the Zbtb46-GFP pos CDPs were segregated away from the pre-cDC2s (Fig. 1e) . Thus, these results indicate that Zbtb46-GFP pos CDPs are an earlier and distinct stage of cDC1 specification compared with the more abundant pre-cDC1 described previously.
scRNA-seq of the CDP identifies factors associated with cDC1 specification. The identification of Zbtb46-GFP-expressing cells in the CDP that had almost exclusive cDC1 potential suggested that the CDP might contain cells that have already specified to cDC1 fate. scRNA-seq was performed on 9,554 CDPs defined as Lin
-cells (Fig. 2a) on the 10x Genomics platform to assay for unrecognized heterogeneity within this population. Uniform Manifold Approximation and Projection (UMAP) analysis [27] [28] [29] identified eight connected clusters (Fig. 2b,c) . Although it was possible to identify genes that were specifically enriched in certain clusters, others such as Klf4 and Ly6d were not enriched in any one cluster (see Supplementary Fig. 1b) . However, scRNA-seq could identify a cluster that was enriched in Zbtb46 expression, corroborating the data above with the Zbtb46-GFP reporter mice. Zbtb46 was expressed in cluster 3, which also showed restricted expression of Id2 and Batf3, but excluded expression of Tcf4 and Zeb2 (Fig. 2d,e) . Cluster 3 also showed reduced Csf1r expression (Fig. 2d) , consistent with lower CD115 surface protein levels in pre-cDC1 and incongruent with the higher CD115 surface protein levels in the bulk CDP (Fig. 1a) . As expected, Flt3 and Irf8 were uniformly and highly expressed (Fig. 2d,e) . Cluster 7, the only other Tcf4-negative cluster, probably contained macrophage or neutrophil contamination because this cluster expressed Ccl6 and did not contain many cells (Fig. 2c,d ). Other factors impacting DC development such as Bcl11a, Spi1, Klf4 and Notch2 (refs. [30] [31] [32] [33] ) were not differentially expressed across the CDP, perhaps suggesting that specification of cDC2s and pDCs occurs after the CDP (Fig. 2d and see Supplementary Fig. 1b ). In addition, the CDP appeared to be homogeneous with respect to markers of proliferation (Fig. 2f) . Thus, scRNA-seq identifies a cluster of cells within the CDP that coordinately induces Nfil3, Id2, Batf3 and Zbtb46 and reduces Tcf4 and Zeb2, suggesting that these genes may regulate cDC1 specification at an earlier stage than previously recognized.
Specification of cDC1s is functionally characterized by low Zeb2
and high Id2 expression. To test the functional importance of these genes for cDC1 specification, two reporter mouse lines expressing a ZEB2-EGFP fusion protein (Zeb2 egfp ) 34 or an Id2-IRES-GFP cassette (Id2 gfp ) 35 were analyzed. Both reporters exhibit green fluorescent protein (GFP) expression consistent with the level of Zeb2 or Id2 gene expression across many immune lineages (see Supplementary  Fig. 2a,b) . In Zeb2 egfp mice, 90% of CDPs expressed high levels of ZEB2-EGFP, but 10% expressed low levels of ZEB2-EGFP, similar to the low levels of ZEB2-EGFP expressed by pre-cDC1s (Fig.  3a) . In Id2 gfp mice, 94% of CDPs expressed low Id2-GFP, but 6% expressed high levels of Id2-GFP similar to the high levels of Id2-GFP expressed by pre-cDC1s (Fig. 3b) Next, the developmental potential of CDPs expressing high or low levels of ZEB2-EGFP, Id2-GFP and Zbtb46-GFP was analyzed in an in vitro Flt3L culture system. CDPs expressing low levels of ZEB2-EGFP showed significantly increased cDC1 potential (66%) compared with CDPs expressing high levels of ZEB2-EGFP (26%) (Fig. 3c,e) . Likewise, CDPs expressing high levels of Id2-GFP showed significantly increased cDC1 potential (77%) compared with CDPs expressing low levels of Id2-GFP (30%) at both days 5 and 7 of an in vitro Flt3L culture (Fig. 3d ,e and see Supplementary  Fig. 2c, d ). Finally, CDPs expressing Zbtb46-GFP developed almost exclusively into cDC1s (96%), whereas CDPs lacking Zbtb46-GFP developed into both cDC1s (30%) and cDC2s (70%) (Figs.  1c and 3e) . In all three cases, pDCs developed exclusively from CDPs that were Zbtb46-GFP neg , ZEB2-EGFP hi or Id2-GFP lo (see Supplementary Fig. 2e-j) . These results suggest that CDPs expressing low levels of ZEB2-EGFP or high levels of Id2-GFP are biased toward cDC1 development, but not as completely as CDPs expressing Zbtb46-GFP.
The transcriptional profile of CDPs expressing low levels of ZEB2-EGFP or high levels of Id2-GFP suggests that these cells are a population intermediate between non-specified CDPs and precDC1s ( Fig. 3f-i) . Genes with expression that differed more than fivefold between the pre-cDC1s and either ZEB2-EGFP hi CDPs (Fig. 3f,g ) or Id2-GFP lo CDPs (Fig. 3h,i (Fig. 3f-i) . Both of these populations also show increasing Zbtb46 expression compared with the non-specified CDPs. Although these three cDC1-specified CDP populations differ in cDC1 potential, their transcriptional profiles suggest that they are highly overlapping. In summary, CDPs that express low ZEB2-EGFP or high Id2-GFP represent an earlier stage of cDC1 specification compared with the previously identified pre-cDC1.
Nfil3 is required for cDC1 specification within the CDP. Nfil3 is required for cDC1 development 16 , but its mechanism and , Zbtb46-GFP neg CDPs and pre-cDC1s and n = 3 for pre-cDC2s). d,e, Zbtb46-GFP pos CDPs, Zbtb46-GFP neg CDPs, pre-cDC1s and pre-cDC2s were purified as in c and analyzed using gene expression microarrays. Expression of transcription factors, with at least fourfold differences between Zbtb46-GFP neg CDPs and pre-cDC1s (d) or hierarchical clustering for genes, with at least eightfold differences between Zbtb46-GFP neg CDP and pre-cDC1s (e), are shown (results averaged from biological triplicates for Zbtb46-GFP pos CDPs, Zbtb46-GFP neg CDPs and pre-cDC1 or biological replicates for pre-cDC2). timing of action remain obscure. To determine the stage where Nfil3 acts in cDC1 development, Nfil3 −/− mice were crossed with ZEB2-EGFP, Id2-GFP and Zbtb46-GFP reporter mice, and it was assayed whether cDC1-specified progenitors developed in the BM. In Nfil3
Zbtb46
gfp/+ reporter mice, cDC1-specified cells can be identified as CD117 ) (pooled from three independent experiments, n = 5 for ZEB2-EGFP lo and ZEB2-EGFP hi CDPs, n = 4 for Id2-GFP hi and Id2-GFP lo CDPs and Zbtb46-GFP pos and Zbtb46-GFP neg CDPs). Small horizontal lines indicate the mean. f, Hierarchical clustering of genes expressed at least fivefold differently between pre-cDC1s and ZEB2-EGFP hi CDPs (results averaged from three independent experiments). g, Expression of the indicated genes described in f. h, Hierarchical clustering of genes expressed at least fivefold differently between pre-cDC1s and Id2-GFP lo CDPs (results averaged from two independent experiments). i, Expression of the indicated genes described in h. Data are presented as the mean and the two-tailed, unpaired, Student's t-test was used to compare groups. **P < 0.01, ****P < 0.0001. . Within the CDP, cDC1-specified cells can be identified as Zbtb46-GFP pos cells that comprise 5% of the CDP (Fig. 4a,b) . However, these cells are also absent in Nfil3 and f are presented as the mean and the two-tailed, unpaired, Student's t-test was used to compare groups. ***P < 0.001; ****P < 0.0001. Fig. 4c,d ). However, these cells are absent in Nfil3
BM (
egfp/+ reporter mice, cDC1-specified CDPs can be identified as ZEB2-EGFP lo cells, which comprise 7% of CDPs (Fig. 4c,d (Fig. 4e,f) . However, these cells are absent in Nfil3
Id2
gfp/+ mice. Furthermore, cDC1-specified CDPs can be identified as Id2-GFP hi cells, which comprise 7% of CDPs (Fig. 4e, f) , but are absent in Nfil3
gfp/+ mice. In summary, Nfil3 is required for the appearance of all cDC1-specified progenitors identified by Zbtb46-GFP, ZEB2-EGFP or Id2-GFP.
Zeb2 functions downstream of Nfil3 in cDC1 specification. Next, the interactions between Nfil3 and other factors were evaluated using genetic mutants rather than GFP reporters. First, interactions between Nfil3 and Zeb2 were examined. ). The development of cDC1s and the presence of cDC1-specified progenitors in Nfil3
−/− and Nfil3
−/−
Zeb2 −/− mice was examined (Fig. 5) . First, Zeb2 −/− mice had a more than twofold increase in splenic cDC1s compared with WT mice (Fig. 5a,b) , consistent with a previous study 20 . Furthermore, Nfil3 −/− mice lacked cDC1s in the spleen, as previously reported 16 . However, Nfil3
Zeb2
−/− mice had a splenic cDC1 population which, similar to Zeb2 −/− mice, was about twofold greater than in WT mice. Similarly, in vitro cDC1 development was increased in Zeb2 −/− BM and reduced in Nfil3 −/− BM (Fig.  5c,d ). However, in vitro cDC1 development from Nfil3
BM was increased compared with Nfil3
−/− BM. Finally, direct examination of pre-cDC1 development was carried out in these mice.
Zeb2
−/− mice had increased numbers of pre-cDC1s compared with WT mice, whereas Nfil3 −/− mice had greatly reduced numbers of pre-cDC1s (Fig. 5e,f) . However, Nfil3
−/−

Zeb2
−/− mice had markedly restored pre-cDC1 development compared with Nfil3 −/− mice. In summary, for both in vivo and in vitro cDC1 development and for in vivo cDC1 specification, the phenotype of Zeb2 deficiency dominates over that of Nfil3 deficiency, suggesting that Zeb2 genetically functions downstream of Nfil3. The repression of Zeb2 by Nfil3 is required in the early stages of cDC1 specification.
Zeb2 functions downstream of Id2 with respect to cDC1 specification. Some evidence suggests that Zeb2 may function genetically upstream of Id2 in cDC1 development 19, 20 , but no mechanism has been established. To evaluate the genetic interaction between WT Zeb2 ), respectively. First, pre-cDC1 specification and cDC1 development were evaluated in these mice (Fig. 6a-d) .
−/− mice showed a twofold increase in cDC1s and pre-cDC1s compared with WT mice, similar to mice with Zeb2 deficiency generated using poly(I:C) and Mx1-Cre (Fig. 5) . Id2 −/− mice lacked splenic cDC1s, as expected 18 and also lacked pre-cDC1s in BM. However, Zeb2
−/−
Id2
−/− mice showed a restored development of 
Zbtb46-GFP -
Zbtb46-GFP
Irf8 ( 1,500
Zeb2 ( (blue) cells were separately analyzed for CD115 and CD135 expression (data representing five independent experiments, n = 5 mice). g, CDPs and Zbtb46-GFP pos cells in f were sort purified and analyzed by gene expression microarray. The gene expression levels are shown for Zeb2, Nfil3 and Batf3 (data representing three independent experiments, n = 2 for CDPs and n = 3 for Zbtb46-GFP pos cells). Small horizontal lines indicate the mean. Data are shown as the mean and the two-tailed, unpaired, Student's t-test was used to compare groups. *P < 0.05, **P < 0.01; ****P < 0.0001; AU, arbitrary units. splenic cDC1s and BM pre-cDC1s (Fig. 6a-d) . Moreover, similar results were obtained from in vitro Flt3L cultures of BM cells from these mice (see Supplementary Fig. 4a,b) Supplementary  Fig. 5a ). In addition, Id2 (Fig. 6f ) and in transcriptional profile ( Fig. 6g and see Supplementary Fig. 5c and Supplementary Table  7) . However, in Id2 
Zbtb46
gfp/+ chimeras, implying a partial block in development of specified cDC1s. In addition, these cells failed to induce Batf3 but maintained expression of Zeb2 compared with Id2
+/+
Zbtb46-GFP
pos cells (Fig. 6g and see Supplementary  Fig. 5c ). These results confirm a role for Id2 in inducing Batf3 and repressing Zeb2 expression during cDC1 specification. As Id2 inhibits E-protein transcription factors, Id2 might indirectly repress Zeb2 if E-proteins supported Zeb2 expression. In agreement, E2A is expressed in CDPs and binds to E-box motifs in the Zeb2 locus based on chromatin immunoprecipitation-sequencing analysis (see Supplementary Fig. 5d-f ) 36 .
Id2 induction imposes a switch in Irf8 enhancer usage during cDC1 development. Data have revealed that E-proteins may be necessary for the sufficient induction of Irf8 in the CDP by activating the +41-kb Irf8 enhancer 15 . This enhancer is transiently active during cDC1 progenitor development, but is required for the development of both pre-cDC1s and cDC1s in vivo 9, 37 . This 454-basepair (bp) region contains six E-box motifs that are conserved between human and murine Irf8 loci (Fig. 7a) , and is known to bind E2-2 in human pDCs (see Supplementary Fig. 6 ) 38 . Using the 454-bp region in a retroviral (RV) reporter system 9 , robust activity was found that was specific for pDCs, but not for cDC1s or cDC2s (Fig. 7b,c) . The activity of three individual enhancer segments, each containing two E-box motifs, was also examined. Segments A and C showed reduced overall activity compared with the 454-bp enhancer, but retained pDC specificity, whereas the middle segment B retained overall activity, but reduced pDC specificity (Fig. 7b,c) . Mutation of both E-boxes 1 and 2 in the 454-bp enhancer notably reduced enhancer activity in pDCs (see Supplementary Fig. 7a,b) . Within segment A, mutation of either E-box alone reduced overall activity, whereas mutation of both E-boxes together completely extinguished activity (Fig. 7d and see Supplementary Fig. 7c ). The most active segment, B, was also E-box dependent, showing reduced overall activity upon mutation of E-boxes 3 and 4 ( Fig. 7e and see Supplementary Fig. 7d ). These results indicate that the +41-kb Irf8 enhancer activity relies on the redundant activity of the six E-box motifs contained within this 454-bp region. In agreement with the role of Id2 in repressing E-proteins that act at E-box motifs, overexpression of retroviral Id2 diminished +41-kb Irf8 enhancer activity (Fig. 7f) .
This suggests that Id2 induction in the CDP can extinguish E-protein activity at the +41-kb Irf8 enhancer, thereby imposing a requirement for a new enhancer in pre-cDC1s to maintain Irf8 expression necessary for cDC1 development. To identify a potential enhancer, ATAC-seq was performed on the macrophage and DC precursor (MDP), CDP and pre-cDC1 progenitors, and a peak was found that indicated accessibility within the Irf8 region only in the pre-cDC1s and the mature cDC1s, but not in the earlier MDPs, CDPs or mature cDC2s (Fig. 7g, red dashed line) . This peak was located at +32 kb of the Irf8 transcription start site and was shown to bind BATF3 9 . The induction of Id2, and the subsequent repression of Zeb2, thus forces a new requirement for Batf3 in maintaining Irf8 expression during cDC1 development.
Discussion
The present study resolves several long-standing puzzles with regard to cDC1 development. First, Id2 was proposed to be required for cDC development by excluding pDC fate potential 23, 24 , but Id2 −/− mice lacked only cDC1s, and did not show the expected loss of all cDCs 17 . Second, cDC1s develop from CDPs that express Irf8 independently of Batf3, yet later become dependent on Batf3 to maintain Irf8 expression. The basis for this switch from Batf3-independent to Batf3-dependent Irf8 expression was unclear. Third, mature cDC1s do not express E-proteins or show +41-kb Irf8 enhancer activity, yet their development requires both. These apparent inconsistencies all result from a cryptic stage in cDC1 development in which Irf8 expression relies on the E-protein-dependent +41-kb Irf8 enhancer. In the present study, this cryptic stage of development was examined to reveal the hierarchy of transcription factors governing cDC1 specification.
The results of the present study define a genetic hierarchy that unifies the actions of known transcription factors required for cDC1 development. cDC1s were known to require Irf8, Batf3, Id2 and Nfil3, but how these factors interacted was unknown. Zbtb46-GFP was used to identify an earlier stage of cDC1 specification than previously described, which occurs within the CDP itself 9 . scRNAseq of the CDP identified a cluster of cells defined by the expression pattern of Nfil3, Id2 and Zeb2. Epistatic analysis revealed a genetic hierarchy in which Nfil3 induces a transition from CDPs that express high levels of Zeb2 and low levels of Id2 to CDPs that express Data are presented as the mean, and a one-way or two-way ANOVA was used to compare groups. *P < 0.05, **P < 0.01, ****P < 0.0001.
high levels of Id2 and low levels of Zeb2. A circuit of mutual repression between Zeb2 and Id2 stabilizes these distinct states, such that repression of Zeb2 by Nfil3 is required to induce this transition. In Zeb2 hi and Id2 lo CDPs, Irf8 expression is maintained by the +41-kb Irf8 enhancer, which is dependent on E-proteins for activity. Upon Id2 induction, E-protein activity is lost and Irf8 expression becomes dependent on Batf3, acting at the +32-kb Irf8 enhancer. It is currently unclear whether Nfil3 directly represses Zeb2 and whether Zeb2 directly represses Id2, because there may be other factors in this proposed genetic circuit. Nfil3 acts largely as a repressor 21, 39 , but may activate transcription in other contexts 40 . Likewise, Zeb2 has been suggested to directly repress Id2 expression 19, 20 , although this has not been rigorously tested. Nfil3, Zeb2 and Id2 have also been shown to regulate innate lymphoid cell development 41 , but the mechanisms by which these transcription factors act in these cells have not been studied.
Although the present study seems to clarify several outstanding questions in cDC1 development, it may raise the possible necessity of a revised DC development scheme. A cDC1-specified stage was identified that occurs before the development of the pre-cDC1s. The cells in this stage express a high level of Irf8, consistent with the high level of Irf8 in the CDP. Early expression of Irf8 seems to correlate with commitment to the cDC1 lineage, as shown recently in a report in which IRF8 expression in human hemopoietic stem cells specifies the cDC1 lineage 42 . cDC1 specification may occur even earlier than this report suggests, but may rely on a minimum threshold of Irf8 expression, and not simply early expression in the BM. The requirement of the +41-kb Irf8 enhancer to increase IRF8 levels during the transition from the MDP to the CDP for subsequent cDC1 specification is consistent with this idea. A revised DC development model may require a deeper understanding of the relationship between IRF8 expression level and activity.
The present results also suggest that cDC1 development may be more closely related to pDC development than previously appreciated. The actions of the proposed genetic circuit on the +41-kb Irf8 enhancer suggest that Id2 extinguishes E-protein activity at the +41-kb Irf8 enhancer and imposes a requirement for Batf3 at the +32-kb Irf8 enhancer. It is possible that pDCs and cDC1s share a common progenitor. The emergence of pDCs from myeloid or lymphoid BM progenitors is debated, because early studies suggested that pDCs can arise from both lymphoid and myeloid BM progenitors 43 . However, two recent studies indicated that late pDC progenitors emerge from the common lymphoid progenitor and a 'pre-pDC' was described 44, 45 . As these studies did not perform lineage tracing for prior expression of myeloid markers, such as CD115, pDC progenitors conceivably could emerge in a series of stages, which include both myeloid and lymphoid features, as recently suggested 46 . Resolution of whether pDCs and cDC1s share a common progenitor that has segregated from the cDC2 lineage, or simply share molecular transcriptional requirements, will require additional studies.
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Methods
Experimental model and subject details. Mice. WT C57BL6/J mice were obtained from the Jackson laboratory. Zbtb46 gfp/+ mice were as described 26 . 
Zbtb46
gfp/gfp mice. Livers from 1-day-old Id2 creERT2/creERT2 pups were dispersed and cells injected into 4-to 6-week-old, lethally irradiated SJL WT mice (Charles River) and chimeras used 8 weeks after reconstitution. Id2-flox and Id2-IRES-GFP mice 35 were generously donated by G. Belz. Tcf3 GFP/+ mice were generated by crossing the Tcfe2a fl allele (B6.129-Tcf3tm1Mbu/J JAX stock no. 028184) with Vav-iCre mice (JAX stock no. 008610).
All mice were generated, bred and maintained on the C57BL/6 background in the Washington University St Louis School of Medicine specific pathogen-free animal facility. Animals were housed in individually ventilated cages covered with autoclaved bedding and provided with nesting material for environmental enrichment. Up to five mice were housed per cage. Cages were changed once a week, and irradiated food and water in autoclaved bottles were provided freely. Animal manipulation was performed using standard protective procedures, including filtered air exchange systems, chlorine-based disinfection and personnel protective equipment, including gloves, gowns, shoe covers, facemasks and head caps. All animal studies followed institutional guidelines with protocols approved by the Animal Studies Committee at Washington University in St Louis.
Unless otherwise specified, experiments were performed with mice aged between 6 and 10 weeks. No differences were observed between male and female mice in any assays performed, and so mice of both genders were used interchangeably throughout the present study. Within individual experiments, mice used were age-and sex-matched littermates whenever possible. Expression microarray analysis. RNA was extracted using an RNAqueous-Micro Kit (Ambion) or a NucleoSpin RNA XS Kit (Machery-Nagel), and then was amplified using Ovation Pico WTA System (NuGEN) or WT Pico System (Affymetrix), and hybridized to GeneChip Mouse Gene 1.0 ST microarrays (Affymetrix) for 18 h at 45 °C in a GeneChip Hybridization Oven 640. The data were analyzed using the Affymetrix GeneChip Command Console. Microarray expression data was processed using Command Console (Affymetrix, Inc.) and the raw (.CEL) files generated were analyzed using Expression Console software with Affymetrix default Robust Multichip Analysis Gene analysis settings (Affymetrix, Inc.). Probe summarization (Robust Multichip Analysis), quality control analysis and probe annotation were performed according to recommended guidelines (Expression Console Software, Affymetrix, Inc.). Data were normalized by robust multiarray average summarization and underwent quartile normalization with ArrayStar software (DNASTAR). Unsupervised hierarchical clustering of differentially expressed genes was computed using ArrayStar (DNASTAR) with the Euclidean distance metric and centroid linkage method.
Induced gene deletion. Conditional gene deletion in Nfil3
ScRNA-seq. One hundred thousand CDPs were sort purified as Live, Lin 
CD135
+ MHC-II -CD11c -cells. Lineage included CD3, CD105, CD19, Ly6G and Ter119. Single-cell genes were measured with the Chromium system using Chromium Single Cell 3′ Library and Gel Bead Kit v.2 (10x Genomics). Cell density and viability of sorted cells were determined by Vi-CELL XR cell counter (Beckman Coulter), and all processed samples had cell viability at >90%. The cell density was used to impute the volume of single-cell suspension needed in the reverse transcription master mix, to achieve ~6,000 cells per sample. After Gel Bead-in-Emulsion reverse transcription reaction and clean-up, a total of 12 cycles of PCR amplification was performed to obtain complementary DNAs. Libraries for RNA-seq were prepared following the manufacturer's user guide (10x Genomics), profiled using Bioanalyzer High Sensitivity DNA kit (Agilent Technologies) and quantified with Kapa Library Quantification Kit (Kapa Biosystems). Each scRNA-seq library was sequenced in one lane of HiSeq4000 (Illumina). Sequencing data were pooled from two runs of 4,796 and 4,758 individual cells. Run 1 had 2,354 median genes and 85,247 mean reads per cell. Run 2 had 2,247 median genes and 85,265 mean reads per cell. Sequencing was filtered and processed using the Seurat R toolkit 51 .
ATAC-seq. ATAC-seq of DC progenitors was performed using the Omni-ATAC protocol as previously described with minor modifications 37 . MDPs, CDPs and pre-cDC1s (10,000 in total) were sorted from BM as described above and lysed in ice-cold ATAC-RSB buffer containing 0.1% NP40, 0.1% Tween-20 and 0.01% digitonin. Cells were incubated at 4 °C for 3 min, then washed with ATAC-RSB buffer containing only 0.1% Tween-20. Nuclei were spun down by centrifugation and then incubated in 50 µl of transposition buffer (25 µl of 2× TD buffer, 22.5 µl distilled H 2 O, 2.5 µl of Tn5 transposase (Nextera DNA Library Prep Kit, Illumina)) and incubated at 37 °C for 30 min. If 10,000 cells could not be obtained for a certain population, then the quantity of Tn5 transposase was titrated down proportionately to the number of cells obtained, but cells were still incubated in 50 µl total. Transposed DNA was purified with a DNA Clean & Concentrator kit (Zymo Research), eluted in 21 µl of elution buffer and stored at −20 °C until amplification. Three biological replicates for each cell population were obtained and sequenced. ATAC-seq libraries were prepared as previously described, barcoded and sequenced on an Illumina Nextseq.
